coronavirus outbreak
покажите мне double blind critical trial, с большим количеством пациентов, который показал бы действенность местных гриппферонов.
доказательная медицина работает только так.
investigators undertook a second study one year later, using higher daily doses, but observed none of the beneficial effects seen in the first study: frequency of illness, symptom severity, and recovery of rhinovirus from infected patients were similar in the treatment and control groups.
https://thorax.bmj.com/content/thoraxjnl/46/10/706.full.pdf
does not protect
https://academic.oup.com/jid/article/160/4/700/829830
Rhinovirus colds developed in 6.3% of rIFN-βser recipients and 5.3% of placebo recipients. In each study, illness frequency and number of days with subjective colds did not differ between the groups.